CDK20 Polyclonal Antibody

CDK20 Polyclonal Antibody

The CDK20 polyclonal antibody is a highly specific and reliable tool for the detection and analysis of cyclin-dependent kinase 20 (CDK20) protein expression. This antibody has been meticulously developed and rigorously validated to ensure optimal performance in various applications, including western blotting, immunohistochemistry, and immunofluorescence.

CDK20 is a member of the cyclin-dependent kinase family, which plays a crucial role in cell cycle regulation and progression. Aberrant expression or dysregulation of CDK20 has been implicated in various diseases, including cancer. Therefore, the accurate measurement of CDK20 protein levels is of utmost importance in both basic research and clinical settings.

The CDK20 polyclonal antibody exhibits exceptional sensitivity and specificity, enabling precise and reliable detection of CDK20 protein in various sample types. It has been extensively tested and validated using a wide range of cell lines and tissues, ensuring consistent and reproducible results.

This antibody is produced using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It is supplied as a liquid formulation, ready for immediate use without the need for any additional preparation. The CDK20 polyclonal antibody is provided in a convenient size, allowing for multiple experiments and minimizing wastage.

In summary, the CDK20 polyclonal antibody is a valuable tool for researchers and clinicians involved in the study of cell cycle regulation and its implications in disease. Its exceptional sensitivity, specificity, and reliability make it an indispensable asset in various applications, facilitating accurate and insightful analysis of CDK20 protein expression.